Skip to main content

Table 1 Demographics and safety of H1N1 vaccine administration to study groups

From: Assessment of epicutaneous testing of a monovalent Influenza A (H1N1) 2009 vaccine in egg allergic patients

  Patients with Egg allergy Control Subjects
Number of patients 59 10
Age in years (mean) 1-27(5.6) 13-77(45.5)
Male sex (percentage) 41(69.5%) 1(12.5%)
Positive skin test response to H1N1 vaccine 1 0
Reaction post-vaccination None None
Exact 95% Confidence Interval for percentage who can safely receive this vaccine 90.23%, 99.67% 63.06%, 100%